HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thorne Research Rebranding Launches With At-Home Biomarker Tests

This article was originally published in The Rose Sheet

Executive Summary

Thorne Research rebrands, launches at-home biomarker, adds exclusive provider and technology agreements and gains Mitsui Group funding.

You may also be interested in...



Health, Beauty And Wellness News: Warnings, Launches, Funds, Fines

GMP, claim and branding problems in FDA's latest supplement sector warnings; FTC adding up Roca Labs' consumer redress; Thorne's hemp supplement sprouts again; SMPL earns passing grade from Zell Fund; Ocean Spray launches cranberry supplement; and ProMera reformulates full line.

Health, Beauty And Wellness News: Nestle Compleat, FDA Nutrition Strategy

Supplement OWL sports CDX; FDA schedules Nutrition Strategy meeting, improves food substances inventory; Innotech imports Wholy Tea to US; Thorne adds Bommarito to exclusive provider list; and Nestle Compleat line blended for tube-feeding.

Emerson Offers E-Commerce To Help Health Care Practitioners Continue Selling Supplements

At least one-third of consumers who have bought supplements from health care providers currently are buying the products online, with Amazon.com the most common seller, says Adam Carr, CEO of Emerson Ecologics. One driver for the trend, in addition to consumers generally using e-commerce for more products, is that Amazon shifted to include premium supplement brands, those previously available only through doctors or other health care practitioners.

Related Content

Topics

UsernamePublicRestriction

Register

RS121447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel